Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Sep;83(3):317-23.
doi: 10.1016/j.antiviral.2009.06.002. Epub 2009 Jun 23.

Comparative analysis of in vitro processivity of HIV-1 reverse transcriptases containing mutations 65R, 74V, 184V and 65R+74V

Affiliations
Comparative Study

Comparative analysis of in vitro processivity of HIV-1 reverse transcriptases containing mutations 65R, 74V, 184V and 65R+74V

Prem L Sharma et al. Antiviral Res. 2009 Sep.

Abstract

While HIV-1 reverse transcriptase (RT) mutations of M to V at position 184 are commonly observed in the clinic, the double mutation of 65R+74V is rarely seen. It has been demonstrated that rapid R-->K reversion occurs at RT codon 65 during replication of HIV-1 in human peripheral blood mononuclear cells containing 65R+74V mutations and that processivity of the RT is reduced relative to wild type. However, clinical studies show that M184V can be detected after several months of therapy interruption, suggesting more effective processivity. Herein, the in vitro RT processivity of genetically engineered M184V and double mutant 65R+74V was compared. Virion-associated RTs of WT pNL4-3, K65R, L74V, M184V and 65R+74V were used to perform RT processivity assays in the presence of trap, poly(rC)-oligo(dG). Both RTs with 184V and 65R+74V mutations exhibited similar processivity when compared with each other and a significantly decreased processivity as compared to WT RT. Both mutant RTs synthesized shorter cDNA molecules (37-42 nt) relative to WT RT, which made longer (65-70 nt) cDNA molecules. Since these surprising biochemical results cannot explain the clinical phenotype, a hypothesis is presented to explain the discrepancy and suggest new approaches for future testing.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Reduced processivity of RTs containing mutations 65R, 74V, 65R+74V and 184V
The purified cDNA products were run on a 6% polyacrylamide vertical gel electrophoresis. The cDNA bands were visualized by autoradiography. The image contrast for whole gel was adjusted to visualize the relative cDNA densities among different lanes (A). Lanes: 1, WT (no trap); 2, 3, WT; 4–7, 65R; 8, 65R (no trap); 9, 10, 74V; 11, 12, 65R+74V; 13, 14, 184V. Relative amounts of cDNA synthesized with WT and entire mutant panel were quantified by Intelligent Quantifier (Bio Image Systems, Inc.) software. The groups of 6 cDNA bands from bottom to the top were scanned for each lane and plotted against cDNA length (Figure 1B and 1C).
Fig. 1
Fig. 1. Reduced processivity of RTs containing mutations 65R, 74V, 65R+74V and 184V
The purified cDNA products were run on a 6% polyacrylamide vertical gel electrophoresis. The cDNA bands were visualized by autoradiography. The image contrast for whole gel was adjusted to visualize the relative cDNA densities among different lanes (A). Lanes: 1, WT (no trap); 2, 3, WT; 4–7, 65R; 8, 65R (no trap); 9, 10, 74V; 11, 12, 65R+74V; 13, 14, 184V. Relative amounts of cDNA synthesized with WT and entire mutant panel were quantified by Intelligent Quantifier (Bio Image Systems, Inc.) software. The groups of 6 cDNA bands from bottom to the top were scanned for each lane and plotted against cDNA length (Figure 1B and 1C).
Fig. 1
Fig. 1. Reduced processivity of RTs containing mutations 65R, 74V, 65R+74V and 184V
The purified cDNA products were run on a 6% polyacrylamide vertical gel electrophoresis. The cDNA bands were visualized by autoradiography. The image contrast for whole gel was adjusted to visualize the relative cDNA densities among different lanes (A). Lanes: 1, WT (no trap); 2, 3, WT; 4–7, 65R; 8, 65R (no trap); 9, 10, 74V; 11, 12, 65R+74V; 13, 14, 184V. Relative amounts of cDNA synthesized with WT and entire mutant panel were quantified by Intelligent Quantifier (Bio Image Systems, Inc.) software. The groups of 6 cDNA bands from bottom to the top were scanned for each lane and plotted against cDNA length (Figure 1B and 1C).
Fig. 2
Fig. 2. Structural interactions of activated nucleotide
Positions of residues 65 and 74 as found in a covalently trapped catalytic complex of HIV-1 reverse transcriptase, 1rtd.pdb (12), showing potential hydrogen bonds in magenta. Van der Waal surface around Leu74 shows simultaneous contact with aligning template strand residue and Phe 61 on adjacent strand β3. Strand β3 orientation is defined by position of Phe 61 and Lys 65.
Fig. 3
Fig. 3. Flexibility of β3-β4 fingers
Orientation of β3 and β4 varies significantly between a) the catalytic complex, also shown in Figure 2 (12) and b) post incorporation complex derived from 1nq6.pdb by Sarafianos et al. (20). Torsional flexing of finger is centered at the interface of residues 61 and 74. Mutation of L74 to V would be predicted to change mobility vector of β3 and directly impact positioning of residue 65 in the catalytic complex. Reduced rotational freedom of Arg may be responsible for its lessened activity relative to Lys at that position. Residue Met184 is shown positioned beneath the primer nucleotide.

Similar articles

Cited by

References

    1. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 1986;59:284–291. - PMC - PubMed
    1. Arion D, Borkow G, Gu Z, Wainberg MA, Parnaik MA. The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase. J. Biol. Chem. 1996;271:19860–19864. - PubMed
    1. Back NKT, Nijhuis M, Keulen W, Boucher CAB, Oude Essink BB, van Kuilenburg ABP, van Gennip AH, Berkhout B. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 1996;15:4040–4049. - PMC - PubMed
    1. Back NK, Berkhout B. Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type1 reverse transcriptase. Antimicrob. Agents Chemother. 1997;41:2484–2491. - PMC - PubMed
    1. Bakhanashvili M. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene. 2001;20:7635–7644. - PubMed

Publication types

Substances